Talk to your doctor about Flore.
A one-pager you can hand to your physician, GI specialist, or telehealth provider. Two minutes to read. Designed to make the conversation faster.
Your patient is considering a personalized probiotic formulated from their gut microbiome. This handout explains what Flore is, how it differs from over-the-counter probiotics, and what questions to ask them.
01What Flore is
Flore Inc. produces personalized probiotic formulas based on whole-genome metagenomic sequencing of the patient's stool sample. Strain selection is informed by the patient's own microbiome composition and clinical history — not a one-size-fits-all blend.
The company has nine years of longitudinal microbiome data across 23,447 patients and 18,000+ sequencing datasets, mapping which strain consortia correlate with which clinical outcomes across multiple body systems (GI, neuro, immune, metabolic, women's health).
02How it's different from off-the-shelf probiotics
Same blend for everyone
Fixed multi-strain dose, no consideration of the recipient's existing microbiome, no strain-level identification of what they actually need more (or less) of.
Sequencing-informed selection
Strain mix is selected after sequencing the patient's stool, with strain-level resolution. Reformulated every 3 / 6 / 12 months based on follow-up sequencing.
03The product tiers your patient may ask about
- GoodOnes — single-strain monthly probiotics ($49–$180). Targeted at one symptom (regularity, bloating, immunity, sleep, mood, skin). Available without sequencing.
- Flore Custom Probiotic — multi-strain formula based on a microbiome test. $297 / $594 / $1069 for 3 / 6 / 12 months. Available direct-to-consumer.
- Flore Clinical — clinician-supervised version of Flore Custom. The clinician has access to the patient's microbiome data and can review the proposed formula.
04Safety profile, briefly
- All strains are GRAS-status (Generally Recognized As Safe) commercial probiotic strains used in commercial fermentation and clinical research.
- Standard caveats apply for immunocompromised patients (post-transplant, active chemotherapy, severe neutropenia, central venous catheters): probiotic use should be discussed with the treating physician before initiation.
- Pregnancy, IBD/Crohn's/UC in active flare, recent GI surgery (under 3 months), and severe acute GI illness warrant clinical discussion before probiotic initiation. Most patients in stable or remission states do well.
- The patient can pause use at any time without taper.
05If you have a microbiome report from another lab
Flore can accept GI-MAP, Genova, Diagnostic Solutions, Vibrant Wellness, BiomeFx, and several other stool-microbiome panel results in addition to its own sequencing. If the patient brings prior testing, Flore can incorporate that data into formula design rather than re-running the panel.
Questions to ask your patient
- What symptoms are you trying to address with this?
- What probiotics have you tried already, and for how long?
- Have you ever had a stool microbiome test done? Can I see the report?
- Are you currently on antibiotics, immunosuppressants, or biologics?
- Any GI surgery, IBD flare, or pregnancy in the last 12 months?
06How to get involved as a clinician
If you'd like to use Flore Clinical with your patients — review their microbiome data, prescribe custom formulas, see longitudinal response — sign up at floreclinical.com. There is no fee to enroll as a clinician, and your patients can elect to share their data with you when they purchase.